Minority Stress Counseling for LGBTQ+ Individuals (MST)

June 6, 2025 updated by: Nicholas C. Borgogna, University of Alabama at Birmingham
Lesbian, gay, bisexual, transgender, and queer+ (LGBTQ+) individuals experience a breadth of mental health disparities. Reducing these disparities is an area of key psychological research. Minority stress is theorized to be an underlying source of the disparities (Meyer, 2003). Minority stress can be conceptualized as the internalized stigma that results from experiences of social marginalization. By reducing minority stress, it is hypothesized that generalized mental illness indicators might be reduced and indicators of wellbeing increased.

Study Overview

Detailed Description

Adult participants will respond to advertisements by emailing a research assistant.

A research assistant will then arrange for a pre-screening interview to ensure inclusion criteria are met.

A research assistant will review informed consent and receive a signed informed consent during the pre-screening.

Participants who are accepted into the study will then be offered up to 12 sessions of ACT or receive an unstructured treatment as usual counseling condition delivered by graduate students in the UAB medical/clinical psychology program under the supervision of Dr. Borgogna. These sessions will be 45 minutes each and delivered in Dr. Borgogna's lab. During the first sessions a survey battery will be administered on a lab secure computer administered via Qualtrics. It will be re-administered at session six, and during the last session.

The survey will include a broad base of demographic, mental health, and minority stress measures.

Participants will be assigned a random number that will link their survey responses across sessions. Identifying information will not be gathered as part of data collection.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Nicholas Borgogna (Assistant Professor), PhD
  • Phone Number: 7579693677
  • Email: borgogna@uab.edu

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35294
        • Recruiting
        • University of Alabama at Birmingham
        • Contact:
        • Contact:
          • Nicholas Borgogna
        • Principal Investigator:
          • Nicholas Borgogna, PhQ

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Must identify as non-heterosexual

Exclusion Criteria:

Suicide attempt within the past 12 months.

Current eating disorder.

Narcotics use within the past 3 months

Non-suicidal self-injury within the past 6 months.

Current/History of psychosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment Group
Participants receiving acceptance and commitment therapy
Up to 16 session of unstructured counseling therapy informed by Acceptance and Commitment Therapy tradition.
Active Comparator: Treatment as usual
Unstructured counseling intervention
Unstructured counseling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alcohol Problems
Time Frame: 16 Weeks
Alcohol Use Disorders Identification Test
16 Weeks
Depression
Time Frame: 12 weeks
Patient Health Questionnaire-9
12 weeks
Anxiety
Time Frame: 12 Weeks
Generalized Anxiety Disorder-7
12 Weeks
Post Traumatic Stress
Time Frame: 12 Weeks
Patient Checklist-5
12 Weeks
Internalized Heterosexism
Time Frame: 12 Weeks
Internalized Homophobia Scale
12 Weeks
Discrimination
Time Frame: 12 Weeks
Daily Heterosexist Questionnaire
12 Weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experiential Avoidance
Time Frame: 16 Weeks
Experiential Avoidance Rating Scale
16 Weeks
Affect
Time Frame: 16 Weeks
Positive Negative Affect Schedule
16 Weeks
Problematic Pornography Use
Time Frame: 12 Weeks
Brief Pornography Screen
12 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 15, 2026

Study Registration Dates

First Submitted

September 24, 2024

First Submitted That Met QC Criteria

September 24, 2024

First Posted (Actual)

September 26, 2024

Study Record Updates

Last Update Posted (Actual)

June 11, 2025

Last Update Submitted That Met QC Criteria

June 6, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-300013570
  • NBLAB1 (Other Identifier: UAB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

deidentified data will be shared upon request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Minority Stress

Clinical Trials on Acceptance and Commitment Therapy

Subscribe